Chinese Pla General Hospital
Clinical trials sponsored by Chinese Pla General Hospital, explained in plain language.
-
New stem cell infusion could boost transplant success in rare blood disorder
Disease control ENROLLING_BY_INVITATIONThis early-phase trial tests whether adding specially grown umbilical cord stem cells to a standard bone marrow transplant can improve outcomes for people with severe aplastic anemia, a rare condition where the bone marrow stops making enough blood cells. About 40 participants ag…
Phase: PHASE1, PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Experimental vaccine trains immune system to fight Hard-to-Treat cancers
Disease control OngoingThis early-phase trial tests a personalized vaccine made from a patient's own immune cells, designed to target specific cancer markers (EphA2 and KRAS mutations). The vaccine is given along with chemotherapy and two immunotherapy drugs. The study includes 9 adults with advanced s…
Phase: PHASE1 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
AI that reads faces could spot hidden distress in cancer patients
Diagnosis ENROLLING_BY_INVITATIONThis trial tests whether artificial intelligence can detect anxiety and depression in cancer patients by analyzing their facial expressions and subtle skin color changes from video. The AI uses computer vision to estimate heart rate and read emotional cues, aiming to flag patient…
Sponsor: Chinese PLA General Hospital • Aim: Diagnosis
Last updated Aug 16, 2026 00:00 UTC
-
New cell discovery could speed up pneumonia diagnosis
Diagnosis OngoingThis study looks at whether special cells, called 'showering cells,' found in lung fluid can help doctors diagnose aspiration pneumonia (a lung infection from inhaling food or liquid). Researchers will compare 94 adults with and without the condition to see if these cells are a r…
Sponsor: Chinese PLA General Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:03 UTC
-
New migraine drug tested on 3,000 patients in Real-Life settings
Symptom relief OngoingThis study looks at how well Rimegepant works for treating migraine attacks in everyday life. About 3,000 adults with migraine will take the drug as prescribed by their doctor and report their pain levels, relief timing, and satisfaction. The goal is to see if Rimegepant helps re…
Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Can a smart breathing monitor make waking up from anesthesia safer?
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether a special breathing monitor, called the Integrated Pulmonary Index (IPI), can help doctors decide the safest time to remove a breathing tube after surgery. About 632 adults having planned abdominal surgery will be randomly assigned to either standard care…
Phase: NA • Sponsor: Chinese PLA General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
AI tool could spot hidden diabetes risk in psoriasis patients
Knowledge-focused OngoingThis study looks at medical records from over 1,200 psoriasis patients to find who is most likely to develop insulin resistance, a condition that can lead to diabetes. Researchers will use machine learning to build a simple tool that helps doctors estimate this risk. No new treat…
Sponsor: Chinese PLA General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC